ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

OPTI Optibiotix Health Plc

18.125
0.00 (0.00%)
21 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 18.125 17.75 18.50 18.125 18.125 18.13 111,277 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 6.38 16.52M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 18.13p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £16.52 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 6.38.

Optibiotix Health Share Discussion Threads

Showing 20601 to 20623 of 147650 messages
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older
DateSubjectAuthorDiscuss
09/2/2017
09:49
you are right someuwin, too heavily invested here, but wrong in panicking, i'd say more frustrated. Because i am expecting something soon to lift the sp, but then i have been expecting it for a long time, e.g., the announcement of P & G tie up yonks ago, was meant to have had a good impact. What happened to the DD that should have ended months ago?

Someuwin, i am sure you have a well rounded portfolio, which is a good thing, as your name seems to pop up throughout ADVFN. On most shares i look at, there is posting from you. But, i would imagine that there are quite a few on here who are similar to me with their cash mostly tied up in 1 or 2 shares. If you can believe SM (and with respect, i personally trust no one a BB ), then he is way over exposed to this share.

neftanikoff
09/2/2017
09:43
Neft - I am sure everyone has diverse watchlist of at least 30 companies, some will have done well and some not so in any given time, that is not the point, timing your buy and sell is the key - hindsight is worth sweetbiotix ;-)

As for the bitter twisted michealmouse - he is still repeating the same lies he started with over a year ago, and they are lies, not mistakes. I am not quite bored enough to respond to his lies - I doubt I need to as they are well documented anyway.

elrico
09/2/2017
09:38
The conclusion is obvious Neft - you are way too heavily invested here.

Sell half, invest in a few other companies - then stop panicking!

someuwin
09/2/2017
09:31
It surely does pay to have a more diversified portfolio and not put all your eggs in one basket. The majority of my portfolio is in opti, as i would imagine is the case with a lot of you on here, that is why you can't here a thing against the company.

Now, i am no m'mouse who writes in a disparaging manner on various shares (not just opti) he does not own, because he is a sicko. But although i am a big fan of opti and naturally want it to explode through that 80p barrier, i think it right to comment in a decent way, if you feel things could be done better, e.g. the TATA thing.

By way of a more diverse portfolio, see the undermentioned post that i wrote earlier this year, EVR is now 11.75 G4M is now 641p and even the much maligned Mazzstar (remember him) tipped OXP, which was under 2P is now 3.5. opti has gone up a bit, but is a slowcoach compared to others. Come on opti, the message is , if you can , soh, please RNS something of material value soon, that will get this irritating share price moving upwards.


Neftanikoff - 05 Jan 2017 - 13:19:52 - 18417 of 19741 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI
bah, humbug, now under 63 to buy, not the start to the New Year, i had wanted.
I am not tipping the following share now, because it has gone up so much in the last few weeks, but i wonder if anyone here bought EVRH, VR bringing in the festival shows into your home. They were 4p when i looked at them, now almost doubled, whilst opti has done nothing. Gears 4 music is another that has done so well.

neftanikoff
09/2/2017
09:25
mmm
Announced on April Fool Day

judijudi
09/2/2017
08:58
Would be interesting if he thinks OPTI is the one share to hold.

What is the 1 share that Britain's Buffett says you must own? Find out ONLY on April 1

If you had to bet the ranch on one share listed in London what would it be? I guess most of us would go for a FTSE 100 stock: Tesco, GlaxoSmithKline or maybe Shell. For the man known as Britain's Buffett, Nigel Wray, the answer is not a blue chip but a small cap. For that is how Wray has made his fortune taking large stakes in smaller companies such as Domino's Pizza when no-one had heard of them.

- See more at:

eekorehc
09/2/2017
08:54
In the CEO's interview, he mentioned that they still had £3.2m in cash. Good.

However, as stated above I find it odd.

If you were the CEO why wouldn't you just say the following. Since the half-year results our revenue streams have improved enormously and our cash-burn has reduced substantially. We still have £3.2m in the bank and we'll be generating cash and trading profitably by the end of the year (or some specified date in the future). As a consequence we won't need any more cash for the foreseeable future. Surely you'd say that wouldn't you? However, apart from cash SOH never mentions the key metrics.

Even if he had stated any of the above, at the current SP, the company is valued at £60m and is loss making. You're paying a hefty premium for a business model and products that are not yet proven.

Anyway, it's your money.

michaelmouse
09/2/2017
08:43
It's not strange at all Sukithedog (unless you're Michael Mouse).According to Mouses math, Opti should have closer to £2.2m in the bank at this time because the "Cash Burn will remain high" but instead Opti has a million more at £3.2m.Now, obviously it wouldn't have really mattered if Opti had even £32m sitting in the account because Mousey here would still have created some sort of negative vibe for that too : )Sienna
siennadelekat21
09/2/2017
08:25
Bought another 3k shares this morning which went through on ISDX. Looking forward to the coming weeks and months as anticipated news comes to fruition.
rafboy
09/2/2017
08:00
It's odd because at the half-year stage they reported revenues of approximately £88,000, losses of £615,243 and cash burn around £900,000. Cash was about £3.5m.

There only reported revenue stream is Go-Figure. Even at £25,000 per month which is the most up to date figure given (and won't have been achieved until recently) that gives £238,000 in reported revenues for the full year? As I said, it's odd imo.

michaelmouse
09/2/2017
07:50
How's it strange!!
They Have revenues coming in

sukithedog
09/2/2017
07:35
"Strange how Opti currently have £3.2m cash as of Feb 2017"

Yes I think it's strange as well? It'll be interesting to see the results for 2016.

Odd that he mentions cash in the bank but didn't mention the year's revenues or losses. It's called selective information.

This company will need more dilutive fund raisings imo. Let's wait and see shall we.

I'm quite happy for you to reproduce that post. I'm surprised about the cash position, and looking forward to their results, but I stand by everything I've said and predicted.

For instance, according to the numerous ramp merchants, the SkinBiotix flotation was supposed to be happening last October or November. It's now February 2017.

michaelmouse
08/2/2017
23:51
I agree it's going in the right direction and certainly trust SOH to get the best deals with the MNs.
luminoso
08/2/2017
23:25
Thats the whole point...the strategy (as I think Opti see it) is to keep the IP as a useable product for any application, and when I say keep, I mean control.
The patents Opti have do allow some control, how much remains to be seen.... but I do think they will have enormous value whatever the outcome.
Opti are setting themselves up to be a flexible entity, capable of taking advantage of an ever changing business landscape.
Patience is needed..., but I think all is moving in a positive direction
Tata, or any other major could try and suck it dry... but as long as Opti are providing solutions for this new science, they will be providing a great service (and profit)to these kind of companies....

nicktopten
08/2/2017
22:41
The only thing we have to worry about, is if these huge companies take advantage of us
They could ride on the back of our advanced science, then dump us when they have the knowledge that they want and need
But I think soh is far to astute and experienced a ceo to allow this to happen. Strong patents and watertight agreements. And maybe I'm being over cynical
Although I have had experience of this before
Sanguine

judijudi
08/2/2017
21:50
This sort of thing happens a lot when small companies supply to massive corporates.

Take Imagination Technologies (IMG) they supply grpahics IP into mobile phones etc. Their biggest revenue earner is Apple who have signed multiple licenses to use IMG graphics in all iPhones, iPads etc.

Not once have IMG ever publicly announced an Apple license win via RNS (they usually say something like tier 1 consumer electronics firm or some such) But they will talk about Apple as a customer in their lierature, presentations and reports etc.

Its just the way it is when dealing with the giants. Annoying but not a major issue.

someuwin
08/2/2017
21:03
I get it, thanks, scotty. There is absolutely no evidence that Tata did or did not ok the mention of their name in an interview. The point I am making is that once it is out in the public domain, which of course that interview is, then it should be RNS'd. That is just basic correct practice and I am sure you can get that. If Tata don't want it RNS'd, SOH should not have dropped their name in an interview, which is publicly available. All this talk about having to avoid using a blue chip name to self publicise, well that's exactly what SOH has done in this interview. Otherwise, why bother ?
luminoso
08/2/2017
20:47
Don't get your knickers in a twist scotty1, have you thought that we might get it and you don't get it, jeeeeeezzzz, some people get so uptight, if they don't like what they read. Maybe your happy in limbo land, still it's banter of a type.
neftanikoff
08/2/2017
20:23
The RNS have to be verified word by word by the regulators hence words like 'if successful' 'this could potentially' etc as annoying as it is..this is done for investor protection. If a company guarantees a product to market through an RNS, if it were to never materialise and people invested based on this info, it can cause a lot of trouble down the line for company and shareholder. It is why Rns's are vague as there are strict restrictions on what can be said. Usually a well explained post or interview follow such RNS's as they are not scrutinised word by word.In terms of announcing tata in an rns, if they do not want to be announced in such a way you simply do not announce. I agree it is complete bs but you do not risk souring relations with your largest partner
riskybusiness1
08/2/2017
20:10
You two just don't get it do you ? it's TATA calling the shots not OPTI,in other words it's up to TATA whether OPTI can put it in an RNS.jeeeezzzzz
scotty1
08/2/2017
20:01
Do you remember this post of yours below Michael? Strange how Opti currently have £3.2m cash as of Feb 2017 (even after having hired some other staff). I'm not impressed with you Math buddy : )Siennamichaelmouse - 22 Oct 2016 - 10:24 - 637 of 877 - 1Here's the rub, and my final thought to leave you with for the weekend.OptiBiotix have now shown their hand in terms of future funding.Listen carefully and bear this in mind.They are investing a further £400,000 in the development of a "first product development in just one of it's divisions."Cash at year end will be about £2.5m (end of this month).4 or 5 such product developments would wipe out their cash reserves. That's just 1 product development per division.They are generating very little revenue and cash burn will remain high.If this proposed IPO doesn't go ahead (and there is some doubt) in the near future then cash will run out very quickly.Dilutive fund raisings are on their way.
siennadelekat21
08/2/2017
19:49
1) RNS the TATA partnership, along with the update. soh says there was no time in the interview for everything, then compose a RNS, for the world to see, not a few. I don't buy some of the bulls on here trying to second guess why opti does not do this and that. pi's should not have to continually e/mail so for clarification on certain points.

2) Many more buys than sells this week, but maybe not so in terms of size. If any of the former directors have been selling, then this should be known. The ones who bought on Monday, have not all sold, maybe a very few, and frothy should not have necessarily led to a down turn.

3) re the bulls, don't be too one sided, i, most on here are for this share and hold, but do open yourselves up to a bit of banter!

ps bring on the red ticks, try to make it 5 this time, premium members lol

neftanikoff
08/2/2017
18:53
Judi, can you define solid news ?

ps, well done for the reply (the only one)

neftanikoff
Chat Pages: Latest  830  829  828  827  826  825  824  823  822  821  820  819  Older

Your Recent History

Delayed Upgrade Clock